nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—TNF—leprosy	0.475	1	CbGaD
Epinephrine—TNF—Thalidomide—leprosy	0.36	0.713	CbGbCtD
Epinephrine—CYP1A2—Thalidomide—leprosy	0.0269	0.0533	CbGbCtD
Epinephrine—CYP1A2—Rifampicin—leprosy	0.0261	0.0516	CbGbCtD
Epinephrine—CYP2C9—Thalidomide—leprosy	0.0243	0.0481	CbGbCtD
Epinephrine—CYP2C9—Rifampicin—leprosy	0.0235	0.0465	CbGbCtD
Epinephrine—CYP2C9—Dapsone—leprosy	0.0194	0.0384	CbGbCtD
Epinephrine—CYP3A4—Rifampicin—leprosy	0.0137	0.0271	CbGbCtD
Epinephrine—CYP3A4—Dapsone—leprosy	0.0113	0.0223	CbGbCtD
Epinephrine—Skin necrosis—Thalidomide—leprosy	0.00148	0.0908	CcSEcCtD
Epinephrine—Rales—Thalidomide—leprosy	0.00126	0.0773	CcSEcCtD
Epinephrine—Skin exfoliation—Dapsone—leprosy	0.000964	0.0592	CcSEcCtD
Epinephrine—Psychotic disorder—Dapsone—leprosy	0.000716	0.0439	CcSEcCtD
Epinephrine—Tingling sensation—Thalidomide—leprosy	0.000643	0.0395	CcSEcCtD
Epinephrine—Myocardial ischaemia—Thalidomide—leprosy	0.000643	0.0395	CcSEcCtD
Epinephrine—Drug interaction—Thalidomide—leprosy	0.000557	0.0342	CcSEcCtD
Epinephrine—Skin exfoliation—Thalidomide—leprosy	0.000493	0.0303	CcSEcCtD
Epinephrine—Lightheadedness—Thalidomide—leprosy	0.000462	0.0284	CcSEcCtD
Epinephrine—Pulmonary oedema—Thalidomide—leprosy	0.00046	0.0282	CcSEcCtD
Epinephrine—Erythema—Dapsone—leprosy	0.000441	0.0271	CcSEcCtD
Epinephrine—Hypoglycaemia—Thalidomide—leprosy	0.000384	0.0236	CcSEcCtD
Epinephrine—Cerebrovascular accident—Thalidomide—leprosy	0.000383	0.0235	CcSEcCtD
Epinephrine—Psychotic disorder—Thalidomide—leprosy	0.000366	0.0225	CcSEcCtD
Epinephrine—Tachycardia—Dapsone—leprosy	0.000351	0.0216	CcSEcCtD
Epinephrine—Hypokalaemia—Thalidomide—leprosy	0.000341	0.021	CcSEcCtD
Epinephrine—Insomnia—Dapsone—leprosy	0.000326	0.02	CcSEcCtD
Epinephrine—Hyperglycaemia—Thalidomide—leprosy	0.000292	0.018	CcSEcCtD
Epinephrine—Drowsiness—Thalidomide—leprosy	0.000289	0.0177	CcSEcCtD
Epinephrine—Acute coronary syndrome—Thalidomide—leprosy	0.000285	0.0175	CcSEcCtD
Epinephrine—Renal failure—Thalidomide—leprosy	0.000284	0.0174	CcSEcCtD
Epinephrine—Myocardial infarction—Thalidomide—leprosy	0.000283	0.0174	CcSEcCtD
Epinephrine—TNF—IL23-mediated signaling events—IL23R—leprosy	0.000278	0.0752	CbGpPWpGaD
Epinephrine—Sweating—Thalidomide—leprosy	0.000277	0.017	CcSEcCtD
Epinephrine—Hypoaesthesia—Thalidomide—leprosy	0.000258	0.0159	CcSEcCtD
Epinephrine—Arrhythmia—Thalidomide—leprosy	0.000232	0.0142	CcSEcCtD
Epinephrine—Vomiting—Dapsone—leprosy	0.000229	0.0141	CcSEcCtD
Epinephrine—Mental disorder—Thalidomide—leprosy	0.000227	0.014	CcSEcCtD
Epinephrine—TNF—Canonical NF-kappaB pathway—CYLD—leprosy	0.000223	0.0603	CbGpPWpGaD
Epinephrine—Tension—Thalidomide—leprosy	0.000222	0.0136	CcSEcCtD
Epinephrine—Nervousness—Thalidomide—leprosy	0.000219	0.0135	CcSEcCtD
Epinephrine—Nausea—Dapsone—leprosy	0.000214	0.0131	CcSEcCtD
Epinephrine—Agitation—Thalidomide—leprosy	0.000208	0.0127	CcSEcCtD
Epinephrine—Palpitations—Thalidomide—leprosy	0.0002	0.0123	CcSEcCtD
Epinephrine—Hypertension—Thalidomide—leprosy	0.000195	0.012	CcSEcCtD
Epinephrine—Chest pain—Thalidomide—leprosy	0.000192	0.0118	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000191	0.0117	CcSEcCtD
Epinephrine—Nervous system disorder—Thalidomide—leprosy	0.000181	0.0111	CcSEcCtD
Epinephrine—Tachycardia—Thalidomide—leprosy	0.00018	0.011	CcSEcCtD
Epinephrine—Skin disorder—Thalidomide—leprosy	0.000179	0.011	CcSEcCtD
Epinephrine—Hyperhidrosis—Thalidomide—leprosy	0.000178	0.0109	CcSEcCtD
Epinephrine—Insomnia—Thalidomide—leprosy	0.000167	0.0102	CcSEcCtD
Epinephrine—Paraesthesia—Thalidomide—leprosy	0.000166	0.0102	CcSEcCtD
Epinephrine—Somnolence—Thalidomide—leprosy	0.000164	0.0101	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Thalidomide—leprosy	0.000159	0.00977	CcSEcCtD
Epinephrine—TNF—Canonical NF-kappaB pathway—RIPK2—leprosy	0.000144	0.0389	CbGpPWpGaD
Epinephrine—TNF—Canonical NF-kappaB pathway—NOD2—leprosy	0.00013	0.0352	CbGpPWpGaD
Epinephrine—TNF—TNF receptor signaling pathway —CYLD—leprosy	0.000128	0.0346	CbGpPWpGaD
Epinephrine—Dizziness—Thalidomide—leprosy	0.000122	0.00748	CcSEcCtD
Epinephrine—Vomiting—Thalidomide—leprosy	0.000117	0.0072	CcSEcCtD
Epinephrine—TNF—Apoptosis—LTA—leprosy	0.000112	0.0304	CbGpPWpGaD
Epinephrine—Nausea—Thalidomide—leprosy	0.000109	0.00672	CcSEcCtD
Epinephrine—TNF—Cytokines and Inflammatory Response—IL10—leprosy	9.68e-05	0.0262	CbGpPWpGaD
Epinephrine—TNF—FAS pathway and Stress induction of HSP regulation—RIPK2—leprosy	8.87e-05	0.024	CbGpPWpGaD
Epinephrine—TNF—Toll-like Receptor Signaling Pathway—TLR1—leprosy	8.56e-05	0.0232	CbGpPWpGaD
Epinephrine—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	7.95e-05	0.0215	CbGpPWpGaD
Epinephrine—TNF—Cytokines and Inflammatory Response—HLA-DRB1—leprosy	7.8e-05	0.0211	CbGpPWpGaD
Epinephrine—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—RIPK2—leprosy	7.37e-05	0.0199	CbGpPWpGaD
Epinephrine—TNF—Regulation of toll-like receptor signaling pathway—TLR1—leprosy	6.69e-05	0.0181	CbGpPWpGaD
Epinephrine—PAH—SIDS Susceptibility Pathways—IL10—leprosy	6.61e-05	0.0179	CbGpPWpGaD
Epinephrine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—leprosy	5.91e-05	0.016	CbGpPWpGaD
Epinephrine—TNF—IL27-mediated signaling events—IFNG—leprosy	5.87e-05	0.0159	CbGpPWpGaD
Epinephrine—TNF—Cytokines and Inflammatory Response—IFNG—leprosy	5.69e-05	0.0154	CbGpPWpGaD
Epinephrine—ADRBK1—CXCR4-mediated signaling events—HLA-DRB1—leprosy	5.57e-05	0.0151	CbGpPWpGaD
Epinephrine—TNF—Cytokines and Inflammatory Response—CD4—leprosy	5.5e-05	0.0149	CbGpPWpGaD
Epinephrine—TNF—Regulation of toll-like receptor signaling pathway—CYLD—leprosy	5.29e-05	0.0143	CbGpPWpGaD
Epinephrine—TNF—IL27-mediated signaling events—IL2—leprosy	5.22e-05	0.0141	CbGpPWpGaD
Epinephrine—TNF—Cytokines and Inflammatory Response—IL2—leprosy	5.06e-05	0.0137	CbGpPWpGaD
Epinephrine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	5e-05	0.0135	CbGpPWpGaD
Epinephrine—TNF—Downstream signaling in naïve CD8+ T cells—CD8A—leprosy	4.68e-05	0.0127	CbGpPWpGaD
Epinephrine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	4.66e-05	0.0126	CbGpPWpGaD
Epinephrine—TNF—IL23-mediated signaling events—IFNG—leprosy	4.43e-05	0.012	CbGpPWpGaD
Epinephrine—TNF—Toll-like Receptor Signaling Pathway—TLR2—leprosy	4.36e-05	0.0118	CbGpPWpGaD
Epinephrine—TNF—IL23-mediated signaling events—CD4—leprosy	4.27e-05	0.0116	CbGpPWpGaD
Epinephrine—TNF—Allograft Rejection—IL10—leprosy	4.1e-05	0.0111	CbGpPWpGaD
Epinephrine—TNF—Allograft Rejection—CD40LG—leprosy	4.1e-05	0.0111	CbGpPWpGaD
Epinephrine—TNF—IL23-mediated signaling events—IL2—leprosy	3.93e-05	0.0106	CbGpPWpGaD
Epinephrine—ADRBK1—CXCR4-mediated signaling events—CD4—leprosy	3.93e-05	0.0106	CbGpPWpGaD
Epinephrine—TNF—Aryl Hydrocarbon Receptor Pathway—IFNG—leprosy	3.72e-05	0.0101	CbGpPWpGaD
Epinephrine—SLC22A5—SLC-mediated transmembrane transport—SLC11A1—leprosy	3.61e-05	0.00977	CbGpPWpGaD
Epinephrine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—leprosy	3.48e-05	0.00941	CbGpPWpGaD
Epinephrine—TNF—Vitamin B12 Metabolism—IFNG—leprosy	3.42e-05	0.00926	CbGpPWpGaD
Epinephrine—TNF—Regulation of toll-like receptor signaling pathway—TLR2—leprosy	3.41e-05	0.00921	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by NGF—RIPK2—leprosy	3.38e-05	0.00916	CbGpPWpGaD
Epinephrine—TNF—Aryl Hydrocarbon Receptor Pathway—IL2—leprosy	3.3e-05	0.00894	CbGpPWpGaD
Epinephrine—TNF—Allograft Rejection—HLA-DRB1—leprosy	3.3e-05	0.00894	CbGpPWpGaD
Epinephrine—TNF—TGF-beta Receptor Signaling—IFNG—leprosy	3.27e-05	0.00885	CbGpPWpGaD
Epinephrine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—leprosy	3.09e-05	0.00836	CbGpPWpGaD
Epinephrine—ADRBK1—Innate Immune System—CYLD—leprosy	3e-05	0.0081	CbGpPWpGaD
Epinephrine—TNF—Downstream signaling in naïve CD8+ T cells—IFNG—leprosy	2.79e-05	0.00754	CbGpPWpGaD
Epinephrine—TNF—Folate Metabolism—IFNG—leprosy	2.79e-05	0.00754	CbGpPWpGaD
Epinephrine—PAH—SIDS Susceptibility Pathways—TNF—leprosy	2.52e-05	0.00681	CbGpPWpGaD
Epinephrine—PAH—Metabolism—SDHD—leprosy	2.49e-05	0.00674	CbGpPWpGaD
Epinephrine—TNF—Downstream signaling in naïve CD8+ T cells—IL2—leprosy	2.48e-05	0.0067	CbGpPWpGaD
Epinephrine—TNF—Folate Metabolism—IL2—leprosy	2.48e-05	0.0067	CbGpPWpGaD
Epinephrine—TNF—Allograft Rejection—IFNG—leprosy	2.41e-05	0.00653	CbGpPWpGaD
Epinephrine—TNF—SIDS Susceptibility Pathways—IL10—leprosy	2.38e-05	0.00644	CbGpPWpGaD
Epinephrine—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—leprosy	2.27e-05	0.00615	CbGpPWpGaD
Epinephrine—PAH—Disease—SLC11A1—leprosy	2.23e-05	0.00605	CbGpPWpGaD
Epinephrine—TNF—Selenium Micronutrient Network—IFNG—leprosy	2.21e-05	0.00599	CbGpPWpGaD
Epinephrine—TNF—Allograft Rejection—IL2—leprosy	2.14e-05	0.0058	CbGpPWpGaD
Epinephrine—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—leprosy	2.12e-05	0.00573	CbGpPWpGaD
Epinephrine—ADRBK1—Innate Immune System—RIPK2—leprosy	1.93e-05	0.00522	CbGpPWpGaD
Epinephrine—ADRBK1—Innate Immune System—TLR2—leprosy	1.93e-05	0.00522	CbGpPWpGaD
Epinephrine—SLC22A5—Transmembrane transport of small molecules—SLC11A1—leprosy	1.83e-05	0.00496	CbGpPWpGaD
Epinephrine—ADRBK1—Innate Immune System—NOD2—leprosy	1.75e-05	0.00473	CbGpPWpGaD
Epinephrine—TNF—Spinal Cord Injury—IFNG—leprosy	1.75e-05	0.00473	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—CYLD—leprosy	1.74e-05	0.00472	CbGpPWpGaD
Epinephrine—TNF—Spinal Cord Injury—IL2—leprosy	1.56e-05	0.00421	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—PARK2—leprosy	1.54e-05	0.00417	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—SLC11A1—leprosy	1.42e-05	0.00385	CbGpPWpGaD
Epinephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—leprosy	1.3e-05	0.00352	CbGpPWpGaD
Epinephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—leprosy	1.16e-05	0.00313	CbGpPWpGaD
Epinephrine—SLC22A2—Transmembrane transport of small molecules—SLC11A1—leprosy	1.15e-05	0.00312	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—TLR2—leprosy	1.12e-05	0.00304	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—RIPK2—leprosy	1.12e-05	0.00304	CbGpPWpGaD
Epinephrine—SLC22A1—Transmembrane transport of small molecules—SLC11A1—leprosy	1.08e-05	0.00291	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—NOD2—leprosy	1.02e-05	0.00276	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—CD40LG—leprosy	8.62e-06	0.00233	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—CD8A—leprosy	8.52e-06	0.00231	CbGpPWpGaD
Epinephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—leprosy	8.42e-06	0.00228	CbGpPWpGaD
Epinephrine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—leprosy	8.42e-06	0.00228	CbGpPWpGaD
Epinephrine—ADRBK1—Innate Immune System—CD4—leprosy	8.4e-06	0.00227	CbGpPWpGaD
Epinephrine—ADRA2B—Platelet activation, signaling and aggregation—IL2—leprosy	7.87e-06	0.00213	CbGpPWpGaD
Epinephrine—ADRA2C—Platelet activation, signaling and aggregation—IL2—leprosy	7.35e-06	0.00199	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—RIPK2—leprosy	7.27e-06	0.00197	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—SDHD—leprosy	7.19e-06	0.00195	CbGpPWpGaD
Epinephrine—PAH—Disease—CD4—leprosy	7.09e-06	0.00192	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—SDHD—leprosy	7e-06	0.00189	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—HLA-DRB1—leprosy	6.94e-06	0.00188	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—SDHD—leprosy	6.71e-06	0.00181	CbGpPWpGaD
Epinephrine—ADRA2A—Platelet activation, signaling and aggregation—IL2—leprosy	5.97e-06	0.00161	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—RIPK2—leprosy	5.84e-06	0.00158	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—SDHD—leprosy	5.68e-06	0.00154	CbGpPWpGaD
Epinephrine—ADRBK1—GPCR downstream signaling—IL2—leprosy	5.43e-06	0.00147	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—IFNG—leprosy	5.07e-06	0.00137	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—IL2—leprosy	4.93e-06	0.00133	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—CD4—leprosy	4.89e-06	0.00132	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—CD4—leprosy	4.52e-06	0.00122	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—IL2—leprosy	4.5e-06	0.00122	CbGpPWpGaD
Epinephrine—ADRB3—GPCR downstream signaling—IL2—leprosy	4.36e-06	0.00118	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—IL2—leprosy	4.05e-06	0.0011	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—IL2—leprosy	3.96e-06	0.00107	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—RIPK2—leprosy	3.8e-06	0.00103	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—IL2—leprosy	3.79e-06	0.00102	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—SDHD—leprosy	3.67e-06	0.000993	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—RIPK2—leprosy	3.46e-06	0.000937	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—RIPK2—leprosy	3.43e-06	0.000929	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—RIPK2—leprosy	3.39e-06	0.000917	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—RIPK2—leprosy	3.21e-06	0.000867	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—RIPK2—leprosy	3.16e-06	0.000854	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—SDHD—leprosy	3.14e-06	0.000849	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—IL2—leprosy	3.08e-06	0.000832	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—IL2—leprosy	2.91e-06	0.000788	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—IL2—leprosy	2.84e-06	0.000768	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—RIPK2—leprosy	2.8e-06	0.000758	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—RIPK2—leprosy	2.6e-06	0.000704	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—IL2—leprosy	2.59e-06	0.0007	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—IL2—leprosy	2.58e-06	0.000697	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—IL2—leprosy	2.56e-06	0.000693	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—IL2—leprosy	2.53e-06	0.000684	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—SDHD—leprosy	2.42e-06	0.000655	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—IL2—leprosy	2.39e-06	0.000648	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—IL2—leprosy	2.36e-06	0.000637	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—IL2—leprosy	2.35e-06	0.000635	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IL2—leprosy	2.34e-06	0.000632	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—IL2—leprosy	2.33e-06	0.000629	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—IL2—leprosy	2.3e-06	0.000621	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL2—leprosy	2.17e-06	0.000588	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL2—leprosy	2.14e-06	0.000579	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—IL2—leprosy	2.09e-06	0.000566	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—IL2—leprosy	1.94e-06	0.000526	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL2—leprosy	1.9e-06	0.000514	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL2—leprosy	1.77e-06	0.000478	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL2—leprosy	1.52e-06	0.000412	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL2—leprosy	1.39e-06	0.000375	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL2—leprosy	1.37e-06	0.000372	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL2—leprosy	1.36e-06	0.000367	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL2—leprosy	1.28e-06	0.000347	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL2—leprosy	1.26e-06	0.000342	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL2—leprosy	1.12e-06	0.000304	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL2—leprosy	1.04e-06	0.000282	CbGpPWpGaD
